EMMA News and Press, Emmaus Life Sciences Incorporation From 03/04/22

Emmaus Life Sciences' Real World Data on Endari® Accepted for E-Poster at the 62nd Annual Scientific Meeting of the British Society for Haematology PR Newswire TORRANCE, Calif. , March 4, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), ...

Emmaus Life Sciences to Present at the H.C. Wainwright BioConnect Conference PR Newswire TORRANCE, Calif. , Jan. 4, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA) , a commercial-stage biopharmaceutical company and leader in the treatment o...

Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing Canada NewsWire Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations NEW YORK , Dec. 20, 2...

Virtual Conference for Life Sciences Companies Broadcast Live December 16th Canada NewsWire Company executives will share corporate vision and answer audience questions at VirtualInvestorConferences.com NEW YORK , Dec. 14, 2021 /CNW/ - Virtual Investor Co...

Emmaus Life Sciences Presents Positive Transfusion Data from a Post-Hoc Analysis of its Phase 3 Clinical Study of Endari® in Patients With Sickle Cell Disease at the 63rd American Society of Hematology (ASH) Annual Meeting Analysis Indicates that Patients Requiring Blood Tr...

Life Sciences Virtual Investor Conference: Company Executives Present Live December 16th Company executives will share corporate vision and answer audience questions at VirtualInvestorConferences.com PR Newswire NEW YORK , Dec. 9, 2021 /PRNewswire/ -- Vi...

Emmaus Life Sciences to Webcast Live at Life Sciences Investor Forum on December 16th Emmaus invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com PR Newswire ...

Emmaus Life Sciences' Data on Endari® Accepted for Poster Presentation at the 63rd American Society of Hematology Annual Meeting & Exhibition Emmaus Life Sciences' Data on Endari® Accepted for Poster Presentation at the 63rd American Society of Hematology Annual Me...

Small and Micro-cap investors are invited to attend the Q4 Investor Summit being held on November 16-17, 2021. The event is organized by the Investor Summit Group, recognised as a highly reputed brand for hosting North America’s largest independent investor conferences. Over 90 pre...

Emmaus Life Sciences Reports Third Quarter Financial Results and Business Highlights -- Net Revenues Increased 4% for the Nine Months Ended September 30, 2021 -- PR Newswire TORRANCE, Calif. , Nov. 12, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQ...